+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Osteoarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • PDF Icon

    Report

  • 413 Pages
  • April 2022
  • Region: Global
  • Global Markets Direct
  • ID: 5589955
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis - Drugs In Development, 2022, provides an overview of the Osteoarthritis (Musculoskeletal Disorders) pipeline landscape.

Osteoarthritis (OA) is one of the most common forms of arthritis. It is a chronic condition in which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, medications like non-steroidal anti-inflammatory drugs (NSAIDs) and exercise.

Report Highlights


The Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Osteoarthritis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Osteoarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 13, 39, 27, 2, 5, 80, 23 and 2 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 2, 9 and 7 molecules, respectively.

Osteoarthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope


  • The pipeline guide provides a snapshot of the global therapeutic landscape of Osteoarthritis (Musculoskeletal Disorders).
  • The pipeline guide reviews pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Osteoarthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Osteoarthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Osteoarthritis (Musculoskeletal Disorders)

Reasons to Buy


  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Osteoarthritis (Musculoskeletal Disorders).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Osteoarthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

IntroductionReport CoverageOsteoarthritis - Overview
Osteoarthritis - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes
Osteoarthritis - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type
Osteoarthritis - Companies Involved in Therapeutics DevelopmentOsteoarthritis - Drug ProfilesOsteoarthritis - Dormant ProjectsOsteoarthritis - Discontinued ProductsOsteoarthritis - Product Development Milestones
Featured News & Press Releases
  • Apr 13, 2022: FDA grants Fast Track Designation for Paradigm Biopharmaceuticals phase III osteoarthritis program
  • Apr 08, 2022: TPX-100: OrthoTrophix presents new data suggesting joint bone shape as a possible surrogate marker for virtual joint replacement in knee osteoarthritis
  • Mar 17, 2022: Paradigm Biopharmaceuticals initiates a phase 3 clinical trial in knee osteoarthritis across the U.S
  • Mar 17, 2022: Paradigm has received regulatory and ethics approvals for the PARA_OA_002 clinical trial in the UK.
  • Mar 14, 2022: Medipost begins administration of knee osteoarthritis drug in P2 trial
  • Mar 03, 2022: 4P-Pharma and QuantHealth join forces to conduct AI-based in-Silico clinical trial simulations
  • Feb 17, 2022: Synartro granted European patent
Feb 08, 2022: Enveric Biosciences announces successful synthesis and filing of provisional patent for EV-104a - Cannabinoid + Celecoxib Conjugate
  • Jan 13, 2022: First subjects randomised dosed in PARA_0A_002 phase 3 study in Australia
  • Jan 12, 2022: Paradigm presentation at the 40th Annual J.P. Morgan Healthcare Conference
  • Dec 28, 2021: Kolon TissueGene resumes TG-C phase III studies in the U.S.
  • Dec 13, 2021: FDA approves XBiotech’s IND in rheumatology
  • Dec 03, 2021: Kolon TissueGene to expand indications for TG-C
  • Nov 01, 2021: Two new studies demonstrate in vitro bioactivity potential of micronized dehydrated human amnion chorion membrane (mdHACM) to prevent pathological processes underlying osteoarthritis (OA) and tendinopathy
  • Sep 21, 2021: TPX-100: OrthoTrophix published a new research article demonstrating disease modification in knee osteoarthritis
AppendixMethodologyCoverageSecondary ResearchPrimary ResearchExpert Panel ValidationContact the Analyst
List of Tables
  • Number of Products under Development for Osteoarthritis, 2022
  • Number of Products under Development by Companies, 2022
  • Number of Products under Development by Universities/Institutes, 2022
  • Products under Development by Companies, 2022
  • Products under Development by Universities/Institutes, 2022
  • Number of Products by Stage and Target, 2022
  • Number of Products by Stage and Mechanism of Action, 2022
  • Number of Products by Stage and Route of Administration, 2022
  • Number of Products by Stage and Molecule Type, 2022
  • Osteoarthritis - Pipeline by 20MED Therapeutics BV, 2022
  • Osteoarthritis - Pipeline by 4P-Pharma SAS, 2022
  • Osteoarthritis - Pipeline by Abiogen Pharma SpA, 2022
  • Osteoarthritis - Pipeline by Achelios Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Aclaris Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Adare Pharma Solutions, 2022
  • Osteoarthritis - Pipeline by AfaSci Inc, 2022
  • Osteoarthritis - Pipeline by Ageless Biotech Inc, 2022
  • Osteoarthritis - Pipeline by Akaal Pharma Pty Ltd, 2022
  • Osteoarthritis - Pipeline by Akan Biosciences LLC, 2022
  • Osteoarthritis - Pipeline by AKL Research and Development Ltd, 2022
  • Osteoarthritis - Pipeline by Algomedix Inc, 2022
  • Osteoarthritis - Pipeline by Amgen Inc, 2022
  • Osteoarthritis - Pipeline by Amplicore Inc, 2022
  • Osteoarthritis - Pipeline by Amzell BV, 2022
  • Osteoarthritis - Pipeline by Aprogen Inc, 2022
  • Osteoarthritis - Pipeline by AskAt Inc, 2022
  • Osteoarthritis - Pipeline by Asta Pharmaceuticals Co Ltd, 2022
  • Osteoarthritis - Pipeline by Atlanthera, 2022
  • Osteoarthritis - Pipeline by Aurealis Pharma AG, 2022
  • Osteoarthritis - Pipeline by Axsome Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Bioiberica SAU, 2022
  • Osteoarthritis - Pipeline by BioIntegrate Inc, 2022
  • Osteoarthritis - Pipeline by BioNet Pharma GmbH, 2022
  • Osteoarthritis - Pipeline by Bioorg3.14 LLC, 2022
  • Osteoarthritis - Pipeline by Biosplice Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by BioStem Technologies Inc, 2022
  • Osteoarthritis - Pipeline by Bioventus Inc, 2022
  • Osteoarthritis - Pipeline by BRIM Biotechnology Inc, 2022
  • Osteoarthritis - Pipeline by Buzzz Pharmaceuticals Ltd, 2022
  • Osteoarthritis - Pipeline by Caliway Biopharmaceutics Co Ltd, 2022
  • Osteoarthritis - Pipeline by CAR-T (Shanghai) Biotechnology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Cartesian Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by CarthroniX Inc, 2022
  • Osteoarthritis - Pipeline by Cartilagen Inc, 2022
  • Osteoarthritis - Pipeline by Causeway Therapeutics Ltd, 2022
  • Osteoarthritis - Pipeline by Cellatoz Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Cellics Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by CELLnLIFE Inc, 2022
  • Osteoarthritis - Pipeline by Cells for Cells SA, 2022
  • Osteoarthritis - Pipeline by CellTex Therapeutics Corp, 2022
  • Osteoarthritis - Pipeline by Cellular Biomedicine Group Inc, 2022
  • Osteoarthritis - Pipeline by Chondrogenix Ltd, 2022
  • Osteoarthritis - Pipeline by Cmxtwenty, 2022
  • Osteoarthritis - Pipeline by Cocoon Biotech, Inc., 2022
  • Osteoarthritis - Pipeline by Corestem Inc, 2022
  • Osteoarthritis - Pipeline by CrystalGenomics Inc, 2022
  • Osteoarthritis - Pipeline by Cynata Therapeutics Ltd, 2022
  • Osteoarthritis - Pipeline by Cytonics Corp, 2022
  • Osteoarthritis - Pipeline by Cytopeutics Pte Ltd, 2022
  • Osteoarthritis - Pipeline by Daewoong Pharmaceutical Co Ltd, 2022
  • Osteoarthritis - Pipeline by Dianomi Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by DNX Biopharmaceuticals Inc, 2022
  • Osteoarthritis - Pipeline by Dongkook Pharmaceutical Co Ltd, 2022
  • Osteoarthritis - Pipeline by Eli Lilly and Co, 2022
  • Osteoarthritis - Pipeline by Ensol Biosciences Inc, 2022
  • Osteoarthritis - Pipeline by Enveric Biosciences Inc, 2022
  • Osteoarthritis - Pipeline by Epione Therapeutics BV, 2022
  • Osteoarthritis - Pipeline by Eternity Bioscience Inc, 2022
  • Osteoarthritis - Pipeline by Evgen Pharma Plc, 2022
  • Osteoarthritis - Pipeline by Exostemtech Co Ltd, 2022
  • Osteoarthritis - Pipeline by Flexion Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Genascence Corp, 2022
  • Osteoarthritis - Pipeline by Genequine Biotherapeutics GmbH, 2022
  • Osteoarthritis - Pipeline by General Regeneratives Shanghai Ltd, 2022
  • Osteoarthritis - Pipeline by General Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by GlaxoSmithKline Plc, 2022
  • Osteoarthritis - Pipeline by GPN Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Guangzhou Saliai Stemcell Science and Technology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Gwoxi Stem Cell Applied Technology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Haplnscience Inc, 2022
  • Osteoarthritis - Pipeline by Hisamitsu Pharmaceutical Co Inc, 2022
  • Osteoarthritis - Pipeline by Histogen Inc, 2022
  • Osteoarthritis - Pipeline by Hope Biosciences LLC, 2022
  • Osteoarthritis - Pipeline by Huaxia Source Cell Engineering Group Co Ltd, 2022
  • Osteoarthritis - Pipeline by iCELL Biotechnology Co Ltd, 2022
  • Osteoarthritis - Pipeline by ICM Co Ltd, 2022
  • Osteoarthritis - Pipeline by Immetas Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by ImmuneCyte Inc, 2022
  • Osteoarthritis - Pipeline by ImmunoForge Co Ltd, 2022
  • Osteoarthritis - Pipeline by Inception Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by International Stem Cell Corp, 2022
  • Osteoarthritis - Pipeline by Johnson & Johnson, 2022
  • Osteoarthritis - Pipeline by Juniper Biologics Pte Ltd, 2022
  • Osteoarthritis - Pipeline by Juvena Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Kaken Pharmaceutical Co Ltd, 2022
  • Osteoarthritis - Pipeline by Kangstem Biotech Co Ltd, 2022
  • Osteoarthritis - Pipeline by Kolon TissueGene Inc, 2022
  • Osteoarthritis - Pipeline by Kukje Pharmaceutical Industry Co Ltd, 2022
  • Osteoarthritis - Pipeline by Levolta Pharmaceuticals Inc, 2022
  • Osteoarthritis - Pipeline by LG Chem Ltd, 2022
  • Osteoarthritis - Pipeline by Likarda LLC, 2022
  • Osteoarthritis - Pipeline by Link Biologics Ltd, 2022
  • Osteoarthritis - Pipeline by Link Health Group, 2022
  • Osteoarthritis - Pipeline by Lubris Biopharma, 2022
  • Osteoarthritis - Pipeline by Luye Pharma Group Ltd, 2022
  • Osteoarthritis - Pipeline by Magellan Biologicals Pty Ltd, 2022
  • Osteoarthritis - Pipeline by MDimune Inc, 2022
  • Osteoarthritis - Pipeline by Mecox Cure Med Co Ltd, 2022
  • Osteoarthritis - Pipeline by Medicrinia Co Ltd, 2022
  • Osteoarthritis - Pipeline by MediPost Co Ltd, 2022
  • Osteoarthritis - Pipeline by Medivir AB, 2022
  • Osteoarthritis - Pipeline by MeiraGTx Holdings Plc, 2022
  • Osteoarthritis - Pipeline by Meluha Life Sciences Sdn Bhd, 2022
  • Osteoarthritis - Pipeline by Merck KGaA, 2022
  • Osteoarthritis - Pipeline by Meridigen Biotech Co Ltd, 2022
  • Osteoarthritis - Pipeline by Mesoblast Ltd, 2022
  • Osteoarthritis - Pipeline by MetrioPharm AG, 2022
  • Osteoarthritis - Pipeline by MiMedx Group Inc, 2022
  • Osteoarthritis - Pipeline by Mor Research Applications Ltd, 2022
  • Osteoarthritis - Pipeline by Nanode Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by NeuroBo Pharmaceuticals Inc, 2022
  • Osteoarthritis - Pipeline by New York R&D Center for Translational Medicine and Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Nexbiome Therapeutics, 2022
  • Osteoarthritis - Pipeline by Nordic Bioscience AS, 2022
  • Osteoarthritis - Pipeline by Novartis AG, 2022
  • Osteoarthritis - Pipeline by Novo Nordisk AS, 2022
  • Osteoarthritis - Pipeline by Orbsen Therapeutics Ltd, 2022
  • Osteoarthritis - Pipeline by Organicell Regenerative Medicine Inc, 2022
  • Osteoarthritis - Pipeline by Organogenesis Holdings Inc, 2022
  • Osteoarthritis - Pipeline by OrthoTrophix Inc, 2022
  • Osteoarthritis - Pipeline by Oxacell AG, 2022
  • Osteoarthritis - Pipeline by Paradigm Biopharmaceuticals Ltd, 2022
  • Osteoarthritis - Pipeline by Paras Biopharmaceuticals Finland Oy, 2022
  • Osteoarthritis - Pipeline by Parnia Stem Cell Knowledge-Based Co, 2022
  • Osteoarthritis - Pipeline by Peptinov SAS, 2022
  • Osteoarthritis - Pipeline by Personalized Stem Cells Inc, 2022
  • Osteoarthritis - Pipeline by PersonGen BioTherapeutics (Suzhou) Co Ltd, 2022
  • Osteoarthritis - Pipeline by Pfizer Inc, 2022
  • Osteoarthritis - Pipeline by PhytoHealth Corp, 2022
  • Osteoarthritis - Pipeline by Plakous Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by PlateletBio, 2022
  • Osteoarthritis - Pipeline by PMG PHARM Co Ltd, 2022
  • Osteoarthritis - Pipeline by PrimeGen Global Inc, 2022
  • Osteoarthritis - Pipeline by PrimRNA Inc, 2022
  • Osteoarthritis - Pipeline by Progenitor Therapeutics Ltd, 2022
  • Osteoarthritis - Pipeline by ProteoThera Inc, 2022
  • Osteoarthritis - Pipeline by Regeneus Ltd, 2022
  • Osteoarthritis - Pipeline by Regenosine Inc, 2022
  • Osteoarthritis - Pipeline by Regulaxis SAS, 2022
  • Osteoarthritis - Pipeline by Remedium Bio Inc, 2022
  • Osteoarthritis - Pipeline by ReqMed Co Ltd, 2022
  • Osteoarthritis - Pipeline by Ribomic Inc, 2022
  • Osteoarthritis - Pipeline by Rottapharm Biotech Srl, 2022
  • Osteoarthritis - Pipeline by Runjia (Suzhou) Pharmaceutical Technology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Sclnow Biotechnology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Seikagaku Corp, 2022
  • Osteoarthritis - Pipeline by Serene LLC, 2022
  • Osteoarthritis - Pipeline by Shandong Boan Biotechnology Co Ltd, 2022
  • Osteoarthritis - Pipeline by Shionogi & Co Ltd, 2022
  • Osteoarthritis - Pipeline by Simcere Pharmaceutical Group Ltd, 2022
  • Osteoarthritis - Pipeline by SL Bigen Co Ltd, 2022
  • Osteoarthritis - Pipeline by Steminent Biotherapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Stempeutics Research Pvt Ltd, 2022
  • Osteoarthritis - Pipeline by Synartro AB, 2022
  • Osteoarthritis - Pipeline by Synerkine Pharma BV, 2022
  • Osteoarthritis - Pipeline by Synokem Pharmaceuticals Ltd, 2022
  • Osteoarthritis - Pipeline by Taiwan Bio Therapeutics Co Ltd, 2022
  • Osteoarthritis - Pipeline by Techfields Pharma Co Ltd, 2022
  • Osteoarthritis - Pipeline by TheraBioPharma Inc, 2022
  • Osteoarthritis - Pipeline by Traverse Biosciences Inc, 2022
  • Osteoarthritis - Pipeline by Tremeau Pharmaceuticals Inc, 2022
  • Osteoarthritis - Pipeline by Trialspark Inc, 2022
  • Osteoarthritis - Pipeline by Turn Biotechnologies Inc, 2022
  • Osteoarthritis - Pipeline by Unicocell Biomed Co Ltd, 2022
  • Osteoarthritis - Pipeline by Vitro Diagnostics Inc, 2022
  • Osteoarthritis - Pipeline by WEX Pharmaceuticals Inc, 2022
  • Osteoarthritis - Pipeline by WNT Scientific LLC, 2022
  • Osteoarthritis - Pipeline by Xalud Therapeutics Inc, 2022
  • Osteoarthritis - Pipeline by Xintela AB, 2022
  • Osteoarthritis - Pipeline by Yooyoung Pharm Co Ltd, 2022
  • Osteoarthritis - Pipeline by Zhejiang Yatai Pharmaceutical Co Ltd, 2022
  • Osteoarthritis - Pipeline by Zimmer Biomet Holdings Inc, 2022
  • Osteoarthritis - Dormant Projects, 2022
  • Osteoarthritis - Discontinued Products, 2022

List of Figures
  • Number of Products under Development for Osteoarthritis, 2022
  • Number of Products under Development by Companies, 2022
  • Number of Products under Development by Universities/Institutes, 2022
  • Number of Products by Top 10 Targets, 2022
  • Number of Products by Stage and Top 10 Targets, 2022
  • Number of Products by Top 10 Mechanism of Actions, 2022
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2022
  • Number of Products by Top 10 Routes of Administration, 2022
  • Number of Products by Stage and Top 10 Routes of Administration, 2022
  • Number of Products by Top 10 Molecule Types, 2022
  • Number of Products by Stage and Top 10 Molecule Types, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 20MED Therapeutics BV
  • 4P-Pharma SAS
  • Abiogen Pharma SpA
  • Achelios Therapeutics Inc
  • Aclaris Therapeutics Inc
  • Adare Pharma Solutions
  • AfaSci Inc
  • Ageless Biotech Inc
  • Akaal Pharma Pty Ltd
  • Akan Biosciences LLC
  • AKL Research and Development Ltd
  • Algomedix Inc
  • Amgen Inc
  • Amplicore Inc
  • Amzell BV
  • Aprogen Inc
  • AskAt Inc
  • Asta Pharmaceuticals Co Ltd
  • Atlanthera
  • Aurealis Pharma AG
  • Axsome Therapeutics Inc
  • Bioiberica SAU
  • BioIntegrate Inc
  • BioNet Pharma GmbH
  • Bioorg3.14 LLC
  • Biosplice Therapeutics Inc
  • BioStem Technologies Inc
  • Bioventus Inc
  • BRIM Biotechnology Inc
  • Buzzz Pharmaceuticals Ltd
  • Caliway Biopharmaceutics Co Ltd
  • CAR-T (Shanghai) Biotechnology Co Ltd
  • Cartesian Therapeutics Inc
  • CarthroniX Inc
  • Cartilagen Inc
  • Causeway Therapeutics Ltd
  • Cellatoz Therapeutics Inc
  • Cellics Therapeutics Inc
  • CELLnLIFE Inc
  • Cells for Cells SA
  • CellTex Therapeutics Corp
  • Cellular Biomedicine Group Inc
  • Chondrogenix Ltd
  • Cmxtwenty
  • Cocoon Biotech, Inc.
  • Corestem Inc
  • CrystalGenomics Inc
  • Cynata Therapeutics Ltd
  • Cytonics Corp
  • Cytopeutics Pte Ltd
  • Daewoong Pharmaceutical Co Ltd
  • Dianomi Therapeutics Inc
  • DNX Biopharmaceuticals Inc
  • Dongkook Pharmaceutical Co Ltd
  • Eli Lilly and Co
  • Ensol Biosciences Inc
  • Enveric Biosciences Inc
  • Epione Therapeutics BV
  • Eternity Bioscience Inc
  • Evgen Pharma Plc
  • Exostemtech Co Ltd
  • Flexion Therapeutics Inc
  • Genascence Corp
  • Genequine Biotherapeutics GmbH
  • General Regeneratives Shanghai Ltd
  • General Therapeutics Inc
  • GlaxoSmithKline Plc
  • GPN Therapeutics Inc
  • Guangzhou Saliai Stemcell Science and Technology Co Ltd
  • Gwoxi Stem Cell Applied Technology Co Ltd
  • Haplnscience Inc
  • Hisamitsu Pharmaceutical Co Inc
  • Histogen Inc
  • Hope Biosciences LLC
  • Huaxia Source Cell Engineering Group Co Ltd
  • iCELL Biotechnology Co Ltd
  • ICM Co Ltd
  • Immetas Therapeutics Inc
  • ImmuneCyte Inc
  • ImmunoForge Co Ltd
  • Inception Therapeutics Inc
  • International Stem Cell Corp
  • Johnson & Johnson
  • Juniper Biologics Pte Ltd
  • Juvena Therapeutics Inc
  • Kaken Pharmaceutical Co Ltd
  • Kangstem Biotech Co Ltd
  • Kolon TissueGene Inc
  • Kukje Pharmaceutical Industry Co Ltd
  • Levolta Pharmaceuticals Inc
  • LG Chem Ltd
  • Likarda LLC
  • Link Biologics Ltd
  • Link Health Group
  • Lubris Biopharma
  • Luye Pharma Group Ltd
  • Magellan Biologicals Pty Ltd
  • MDimune Inc
  • Mecox Cure Med Co Ltd
  • Medicrinia Co Ltd
  • MediPost Co Ltd
  • Medivir AB
  • MeiraGTx Holdings Plc
  • Meluha Life Sciences Sdn Bhd
  • Merck KGaA
  • Meridigen Biotech Co Ltd
  • Mesoblast Ltd
  • MetrioPharm AG
  • MiMedx Group Inc
  • Mor Research Applications Ltd
  • Nanode Therapeutics Inc
  • NeuroBo Pharmaceuticals Inc
  • New York R&D Center for Translational Medicine and Therapeutics Inc
  • Nexbiome Therapeutics
  • Nordic Bioscience AS
  • Novartis AG
  • Novo Nordisk AS
  • Orbsen Therapeutics Ltd
  • Organicell Regenerative Medicine Inc
  • Organogenesis Holdings Inc
  • OrthoTrophix Inc
  • Oxacell AG
  • Paradigm Biopharmaceuticals Ltd
  • Paras Biopharmaceuticals Finland Oy
  • Parnia Stem Cell Knowledge-Based Co
  • Peptinov SAS
  • Personalized Stem Cells Inc
  • PersonGen BioTherapeutics (Suzhou) Co Ltd
  • Pfizer Inc
  • PhytoHealth Corp
  • Plakous Therapeutics Inc
  • PlateletBio
  • PMG PHARM Co Ltd
  • PrimeGen Global Inc
  • PrimRNA Inc
  • Progenitor Therapeutics Ltd
  • ProteoThera Inc
  • Regeneus Ltd
  • Regenosine Inc
  • Regulaxis SAS
  • Remedium Bio Inc
  • ReqMed Co Ltd
  • Ribomic Inc
  • Rottapharm Biotech Srl
  • Runjia (Suzhou) Pharmaceutical Technology Co Ltd
  • Sclnow Biotechnology Co Ltd
  • Seikagaku Corp
  • Serene LLC
  • Shandong Boan Biotechnology Co Ltd
  • Shionogi & Co Ltd
  • Simcere Pharmaceutical Group Ltd
  • SL Bigen Co Ltd
  • Steminent Biotherapeutics Inc
  • Stempeutics Research Pvt Ltd
  • Synartro AB
  • Synerkine Pharma BV
  • Synokem Pharmaceuticals Ltd
  • Taiwan Bio Therapeutics Co Ltd
  • Techfields Pharma Co Ltd
  • TheraBioPharma Inc
  • Traverse Biosciences Inc
  • Tremeau Pharmaceuticals Inc
  • Trialspark Inc
  • Turn Biotechnologies Inc
  • Unicocell Biomed Co Ltd
  • Vitro Diagnostics Inc
  • WEX Pharmaceuticals Inc
  • WNT Scientific LLC
  • Xalud Therapeutics Inc
  • Xintela AB
  • Yooyoung Pharm Co Ltd
  • Zhejiang Yatai Pharmaceutical Co Ltd
  • Zimmer Biomet Holdings Inc